LeMaitre Vascular (NASDAQ: LMAT) CEO gifts 11,974 shares, receives dividend rights
Rhea-AI Filing Summary
LEMAITRE VASCULAR INC Chairman and CEO George W. LeMaitre reported a mix of estate-planning and compensation-related equity movements in company securities. He made a bona fide gift of 11,974 shares of common stock, after which his direct holdings stood at 1,418,045 common shares. A related irrevocable life insurance trust for the benefit of his children holds 45,374 common shares, and he disclaims beneficial ownership except for any pecuniary interest. In addition, he received several small grants of dividend equivalent rights tied to prior restricted stock unit and performance share unit awards, each economically equivalent to one share of common stock and vesting proportionately with the underlying awards.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Dividend Equivalent Rights | 4.0092 | $0.00 | $0.00 |
| Grant/Award | Dividend Equivalent Rights | 4.0092 | $0.00 | $0.00 |
| Grant/Award | Dividend Equivalent Rights | 6.854 | $0.00 | $0.00 |
| Grant/Award | Dividend Equivalent Rights | 8.2136 | $0.00 | $0.00 |
| Grant/Award | Dividend Equivalent Rights | 10.0254 | $0.00 | $0.00 |
| Grant/Award | Dividend Equivalent Rights | 11.3593 | $0.00 | $0.00 |
| Grant/Award | Dividend Equivalent Rights | 16.8053 | $0.00 | $0.00 |
| Gift | Common Stock | 11,974 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 11,974 | $0.00 | $0.00 |
Footnotes (8)
- F1. These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.
- F2. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- F3. These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- F4. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- F5. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- F6. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- F7. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- F8. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Key Figures
Key Terms
Dividend Equivalent Rights financial
bona fide gift financial
restricted stock unit award financial
irrevocable trust financial
AI-generated analysis. How Rhea-AI works. Not financial advice.